Clinical trial
A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients: A Two-Center, Randomized, Double-Blind, Placebo-controlled Study
NCT05900752 is registered in ClinicalTrials.gov with Shenzhen Precision Health Food Technology Co. Ltd., as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients: A Two-Center, Randomized, Double-Blind, Placebo-controlled Study
- Lead sponsor
- Shenzhen Precision Health Food Technology Co. Ltd.,
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 19, 2023
- Completion date
- July 16, 2023
- Enrollment
- 140 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea, ibs - irritable bowel syndrome